Anthropic’s Nasdaq IPO roadshow targets $1.2‑$1.3 trillion valuation

Anthropic is targeting a $1.2-$1.3 trillion valuation for its Nasdaq IPO, lower than earlier expectations. The company reported $33.2 billion in revenue for the first nine months of 2026, but also a $104 billion net loss. The IPO, set for mid-November under ticker ANT, will be a benchmark for AI rivals.

Original reporting
Published Nov 13, 2026, 11:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 14, 2026, 1:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Anthropic’s Nasdaq IPO roadshow targets $1.2‑$1.3 trillion valuation — source image
Decision brief

The 30-second read

$ANTNeutralHigh
01

Why it matters

The disclosed valuation and financials provide the first concrete data for pricing the IPO, likely driving significant pre‑market and early‑day trading activity.

02

Market read

Anthropic's IPO could become a reference point for AI valuations, influencing both sector sentiment and broader tech market dynamics.

03

What to watch

The massive compute commitments ($895 B total) could strain cash flow and limit near‑term profitability.

Relevance 9/10Novelty 9/10Timing: ahead of the week of 16 Nov IPO pricing

Background

Anthropic, a leading AI lab backed by Amazon and Google, is preparing its Nasdaq debut with a proposed ticker ANT and a valuation target far exceeding prior AI IPOs.

Company-level read

Ticker impact

$ANTNeutralHigh confidence
Context

The article discloses Anthropic's upcoming Nasdaq IPO details, including a valuation target of $1.2‑$1.3 trillion, S‑1 revenue figures and the planned ticker ANT.

Expected impact

potential downward pressure if valuation exceeds market expectations; upside if pricing is set lower than the $1.2 trillion range.

Evidence & confidence

The disclosed valuation range is far above recent comparable AI IPOs, creating uncertainty that typically translates into volatile trading around the pricing date.

Market effects

Sets a new benchmark for frontier AI labs, influencing valuation expectations for peers like OpenAI and Mistral.

Adds to Nasdaq's AI‑focused listings, potentially boosting investor interest in US tech IPOs.

Highlights the scale of AI capital intensity, affecting global AI investment sentiment.

Counterpoint

Investors may view the trillion‑plus valuation as over‑optimistic and short the IPO at the pricing stage.

Key entities

  • Anthropic

    AI research and development firm planning a Nasdaq IPO.

  • Amazon

    Major shareholder and compute provider to Anthropic.

  • Google

    Major shareholder and compute provider to Anthropic.

Related articles

$ANTHighAI 9/10

Anthropic CEO sells investors on safety, 'no jerks' culture

Anthropic CEO Dario Amodei emphasized AI safety and a strict hiring culture to investors ahead of the company's IPO, targeting enterprise customers. The company set a price range of $70-$78 per share, aiming to raise up to $64.4 billion and value it at about $1.4 trillion. Amodei predicted new markets from AI advancements and stressed the importance of talent and culture.

$ANTHighAI 8/10

Anthropic’s (ANT) IPO Is Six Times Oversubscribed as Investor Demand Builds

Anthropic's (ANT) IPO is six times oversubscribed, with plans to sell 825 million Class A shares at $70-$78 each, potentially raising $64.35 billion. Goldman Sachs (GS) and Morgan Stanley (MS) are underwriters. Trading is expected to start on Nasdaq on Nov. 19, with a valuation of around $1.5 trillion. 20% of shares are reserved for retail investors, double the typical allocation.

$ANTMedAI 8/10

Anthropic Reports Complex Financial Situation Heading Up To IPO

Anthropic, an AI company, reported $16B revenue and $80B loss in its S-1 filing, primarily due to convertible notes held by Amazon. The company holds $132B in cash and plans an IPO projected to raise $100B+, with a potential valuation of up to $2T. Amazon's notes may convert into shares, diluting other shareholders. Traders speculate on its IPO valuation, with odds shifting towards lower values.

$ANTMedAI 8/10

Anthropic IPO shuts out Chinese investors amid US-China tensions

Anthropic's $1.4T IPO excludes Chinese investors due to US ITAR restrictions, per Bloomberg. Banks refuse orders from mainland China and Hong Kong. Investors explore offshore structures. Demand is high, with orders at 6x supply. The company aims to raise $90.4B. Trading starts Nov. 19 on Nasdaq under ANT. The company faces a legal dispute with the Pentagon.